Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: Final report of BMT CTN 2002 Research Letter
| Authors: | Meyers, G.; Hamadani, M.; Martens, M.; Ali, H.; Chevallier, P.; Choe, H.; Harris, A. C.; Holler, E.; van Hooren, E.; Klaassen, W.; Leifer, E.; van Oosterhout, Y.; Perez, L.; Pusic, I.; Stelljes, M.; van der Velden, W.; Ammatuna, E.; Beauvais, D.; Cornillon, J.; Maziarz, R. T.; Schetelig, J.; Romeril, J.; MacMillan, M. L.; Levine, J. E.; SocieĢ, G. |
| Title: | Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: Final report of BMT CTN 2002 |
| Keywords: | adult; clinical article; controlled study; aged; middle aged; drug safety; gastrointestinal hemorrhage; letter; infection; steroid; chronic myeloid leukemia; acute lymphoblastic leukemia; acute graft versus host disease; myeloablative conditioning; myelodysplastic syndrome; death; drug response; graft versus host reaction; reduced intensity conditioning; sepsis; bone marrow transplantation; graft vs host disease; cytopenia; mycosis fungoides; thrombotic microangiopathy; steroids; antibody conjugate; immunoconjugates; acute myeloid leukemia; ruxolitinib; humans; human; mismatched unrelated donor; matched related donor; matched unrelated donor; t guard; t guard (antibody) |
| Journal Title: | Bone Marrow Transplantation |
| Volume: | 58 |
| Issue: | 12 |
| ISSN: | 0268-3369 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2023-12-01 |
| Start Page: | 1416 |
| End Page: | 1418 |
| Language: | English |
| DOI: | 10.1038/s41409-023-02110-4 |
| PUBMED: | 37749187 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Letter -- Erratum issued, see DOI: 10.1038/s41409-025-02534-0 -- Source: Scopus |
